title: The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis.
abstract: OBJECTIVE
  To develop a provisional definition for the evaluation of response to therapy in juvenile dermatomyositis (DM) based on the Paediatric Rheumatology International Trials Organisation juvenile DM core set of variables.
  
  
  METHODS
  Thirty-seven experienced pediatric rheumatologists from 27 countries achieved consensus on 128 difficult patient profiles as clinically improved or not improved using a stepwise approach (patient's rating, statistical analysis, definition selection). Using the physicians' consensus ratings as the "gold standard measure," chi-square, sensitivity, specificity, false-positive and-negative rates, area under the receiver operating characteristic curve, and kappa agreement for candidate definitions of improvement were calculated. Definitions with kappa values >0.8 were multiplied by the face validity score to select the top definitions.
  
  
  RESULTS
  The top definition of improvement was at least 20% improvement from baseline in 3 of 6 core set variables with no more than 1 of the remaining worsening by more than 30%, which cannot be muscle strength. The second-highest scoring definition was at least 20% improvement from baseline in 3 of 6 core set variables with no more than 2 of the remaining worsening by more than 25%, which cannot be muscle strength (definition P1 selected by the International Myositis Assessment and Clinical Studies group). The third is similar to the second with the maximum amount of worsening set to 30%. This indicates convergent validity of the process.
  
  
  CONCLUSIONS
  We propose a provisional data-driven definition of improvement that reflects well the consensus rating of experienced clinicians, which incorporates clinically meaningful change in core set variables in a composite end point for the evaluation of global response to therapy in juvenile DM.
authors.affiliation: Paediatric Rheumatology International Trials Organisation, Genoa, Italy. nicolaruperto@ospedale-gaslini.ge.it
authors.forename: Nicolino
authors.initials: N
authors.lastname: Ruperto
authors.forename: Angela
authors.initials: A
authors.lastname: Pistorio
authors.forename: Angelo
authors.initials: A
authors.lastname: Ravelli
authors.forename: Lisa G
authors.initials: LG
authors.lastname: Rider
authors.forename: Clarissa
authors.initials: C
authors.lastname: Pilkington
authors.forename: Sheila
authors.initials: S
authors.lastname: Oliveira
authors.forename: Nico
authors.initials: N
authors.lastname: Wulffraat
authors.forename: Graciela
authors.initials: G
authors.lastname: Espada
authors.forename: Stella
authors.initials: S
authors.lastname: Garay
authors.forename: Ruben
authors.initials: R
authors.lastname: Cuttica
authors.forename: Michael
authors.initials: M
authors.lastname: Hofer
authors.forename: Pierre
authors.initials: P
authors.lastname: Quartier
authors.forename: Jose
authors.initials: J
authors.lastname: Melo-Gomes
authors.forename: Ann M
authors.initials: AM
authors.lastname: Reed
authors.forename: Malgorzata
authors.initials: M
authors.lastname: Wierzbowska
authors.forename: Brian M
authors.initials: BM
authors.lastname: Feldman
authors.forename: Miroslav
authors.initials: M
authors.lastname: Harjacek
authors.forename: Hans-Iko
authors.initials: HI
authors.lastname: Huppertz
authors.forename: Susan
authors.initials: S
authors.lastname: Nielsen
authors.forename: Berit
authors.initials: B
authors.lastname: Flato
authors.forename: Pekka
authors.initials: P
authors.lastname: Lahdenne
authors.forename: Harmut
authors.initials: H
authors.lastname: Michels
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Murray
authors.forename: Lynn
authors.initials: L
authors.lastname: Punaro
authors.forename: Robert
authors.initials: R
authors.lastname: Rennebohm
authors.forename: Ricardo
authors.initials: R
authors.lastname: Russo
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Balogh
authors.forename: Madeleine
authors.initials: M
authors.lastname: Rooney
authors.forename: Lauren M
authors.initials: LM
authors.lastname: Pachman
authors.forename: Carol
authors.initials: C
authors.lastname: Wallace
authors.forename: Philip
authors.initials: P
authors.lastname: Hashkes
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Lovell
authors.forename: Edward H
authors.initials: EH
authors.lastname: Giannini
authors.forename: Boel Andersson
authors.initials: BA
authors.lastname: Gare
authors.forename: Alberto
authors.initials: A
authors.lastname: Martini
mesh_terms: D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic / Q000592:standards*; D003882:Dermatomyositis / Q000453:epidemiology / Q000628:therapy; D005260:Female; D006801:Humans; D038622:Internationality; D008297:Male; D010372:Pediatrics / Q000592:standards*; D015203:Reproducibility of Results; D012219:Rheumatology / Q000592:standards*; D016896:Treatment Outcome